When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARDS - Amarin's November Rendezvous With A Stepmotherly FDA And Other Headlines: The Good Bad And Ugly Of Biopharma
Aridis Pharmaceuticals Inc.
The FDA has a history of stepmotherly behaviour with Amarin (AMRN). We saw it between 2013 and 2015, when the FDA issued a CRL to Amarin when the company asked for a very reasonable label expansion - and the FDA took an entire year to even issue the CRL. The saga of those sordid years can be seen in the graph below:
In mid-2015, Amarin filed a suit against the FDA, and a few months later, the court ruled in favour of the company. While us investors were amazed at the spunk of this